Physician profile
Sahar Bedrood
NPI 1871851923
$296,923.02
in general payments reported to CMS, 2019-2025
30 companies · $60K in 2025
The $60K reported for 2025 was more than what 97% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $40K · 2021: $25K · 2022: $34K · 2023: $59K · 2024: $57K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $132K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $12K · Travel and Lodging: $5,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,668.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,100.00 |
| Food and Beverage | $11,886.45 |
| Travel and Lodging | $5,145.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $149,475.15 | 2019-2025 | Idose, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Travoprost Intraocular Implant - Idose |
| Allergan, INC. | $61,161.41 | 2019-2022 | |
| Abbvie INC. | $50,554.93 | 2022-2025 | Xen Glaucoma Treatment System, Durysta, Lumigan |
| Beaver-Visitec International, INC. | $10,118.24 | 2023-2025 | |
| Alcon Vision LLC | $9,876.28 | 2019-2025 | Clareon, Unity, Centurion |
| Nova Eye, INC. | $4,712.69 | 2023-2025 | |
| Carl Zeiss Meditec, INC. | $2,800.00 | 2025 | Callisto Eye, Cirrus Hd-Oct, Visumax |
| Tarsus Pharmaceuticals, INC. | $2,182.09 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $2,175.03 | 2020-2021 | |
| Microsurgical Technology, INC. | $750.00 | 2023 | |
| New World Medical,INC. | $726.66 | 2022-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Bausch & Lomb Americas INC. | $381.94 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Sun Pharmaceutical Industries INC. | $295.55 | 2023-2025 | Cequa |
| Sight Sciences, INC. | $293.26 | 2021-2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $262.93 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $222.20 | 2022-2025 | Oxervate |
| Ocular Therapeutix, INC. | $175.13 | 2022-2025 | Dextenza |
| Oyster Point Pharma, INC. | $109.35 | 2022-2025 | Tyrvaya, Ryzumvi |
| Carl Zeiss Meditec USA, INC. | $94.83 | 2024 | Humphrey Hfa |
| Thea Pharma INC. | $86.03 | 2023-2025 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $82.75 | 2022-2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $74.17 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $63.88 | 2019-2024 | Tecnis Simplicity |
| Harrow Eye, LLC | $48.93 | 2025 | Vevye |
| Amgen INC. | $43.83 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $42.76 | 2021-2023 | Tepezza |
| Rxsight INC | $40.84 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Eyevance Pharmaceuticals LLC | $40.78 | 2022-2023 | Flarex |
| Biotissue Holdings INC. | $18.09 | 2022 | |
| Tearlab Corp | $13.29 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sahar Bedrood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.